Literature DB >> 12066831

Effectiveness of Beck Depression Inventory-II subscales in screening for major depressive disorders in adolescent psychiatric inpatients.

Geetha Kumar1, Robert A Steer, Karen B Teitelman, Lourdes Villacis.   

Abstract

The Beck Depression Inventory-II (BDI-II) was administered to 45 male and 55 female psychiatric inpatients who were 12 to 17 years old, and the Mood Module from the Primary Care Evaluation of Mental Disorders (PRIME-MD) was used to determine whether these patients met criteria for a diagnosis of a DSM-IV major depressive disorder (MDD). Binormal receiver-operating-characteristic (ROC) analyses found that BDI-II total scores, Cognitive subscale scores, Noncognitive subscale scores, and embedded BDI FastScreen for Medical Patients subscale scores were comparably effective in differentiating inpatients who were and were not diagnosed with a MDD; the areas under the ROC curves were, respectively, .92 (95% confidence interval [CI]: .85-.96), .90 (95% CI: .82-.95), .90 (95% CI: .83-.95), and .90 (95% CI: .83-.95).

Entities:  

Mesh:

Year:  2002        PMID: 12066831     DOI: 10.1177/10791102009002007

Source DB:  PubMed          Journal:  Assessment        ISSN: 1073-1911


  25 in total

1.  [Reliability and validity of the Revised Beck Depression Inventory (BDI-II). Results from German samples].

Authors:  C Kühner; C Bürger; F Keller; M Hautzinger
Journal:  Nervenarzt       Date:  2007-06       Impact factor: 1.214

2.  Impact of Non-Suicidal Self-Injury Scale: Initial Psychometric Validation.

Authors:  Taylor A Burke; Brooke A Ammerman; Jessica L Hamilton; Lauren B Alloy
Journal:  Cognit Ther Res       Date:  2016-09-13

3.  Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study.

Authors:  Jennifer M Loftis; Alexander L Patterson; Clare J Wilhelm; Henry McNett; Benjamin J Morasco; Marilyn Huckans; Timothy Morgan; Shira Saperstein; Aliya Asghar; Peter Hauser
Journal:  J Psychosom Res       Date:  2012-11-21       Impact factor: 3.006

4.  Factorial and diagnostic validity of the Beck Depression Inventory-II (BDI-II) in Croatian primary health care.

Authors:  Nenad Jakšić; Ena Ivezić; Nataša Jokić-Begić; Zsuzsanna Surányi; Stanislava Stojanović-Špehar
Journal:  J Clin Psychol Med Settings       Date:  2013-09

5.  The relationship between unmet needs and distress amongst young people with cancer.

Authors:  Gavin J Dyson; Kate Thompson; Susan Palmer; David M Thomas; Penelope Schofield
Journal:  Support Care Cancer       Date:  2011-02-11       Impact factor: 3.603

6.  Contamination in the Prospective Study of Child Maltreatment and Female Adolescent Health.

Authors:  Chad E Shenk; Jennie G Noll; James L Peugh; Amanda M Griffin; Heather E Bensman
Journal:  J Pediatr Psychol       Date:  2015-03-21

7.  Exploration of the influence of childhood trauma, combat exposure, and the resilience construct on depression and suicidal ideation among U.S. Iraq/Afghanistan era military personnel and veterans.

Authors:  Nagy A Youssef; Kimberly T Green; Eric A Dedert; Jeffrey S Hertzberg; Patrick S Calhoun; Michelle F Dennis; Jean C Beckham
Journal:  Arch Suicide Res       Date:  2013

8.  The association of academic tracking to depressive symptoms among adolescents in three Caribbean countries.

Authors:  Garth E Lipps; Gillian A Lowe; Sharon Halliday; Amrie Morris-Patterson; Nelson Clarke; Rosemarie N Wilson
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2010-05-28       Impact factor: 3.033

9.  Psychometric properties and cut-off scores of the Beck Depression Inventory-II in Turkish adolescents.

Authors:  Runa I Uslu; Emine G Kapci; Bedriye Oncu; Mert Ugurlu; Hakan Turkcapar
Journal:  J Clin Psychol Med Settings       Date:  2008-08-08

10.  Depressive Symptoms and Suicidal Ideation Among Symptomatic Patients With a History of Lyme Disease vs Two Comparison Groups.

Authors:  Shreya Doshi; John G Keilp; Barbara Strobino; Martin McElhiney; Judith Rabkin; Brian A Fallon
Journal:  Psychosomatics       Date:  2018-03-01       Impact factor: 2.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.